welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
completed
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
study id #: NCT00808743
condition: Familial Adenomatous Polyposis, Duodenal Neoplasms, Duodenal Polyps
status: completed
purpose:Duodenal carcinomas are the leading cause of mortality in patients with Familial Adenomatous Polyposis (FAP) who underwent prophylactic colorectal surgery. The purpose of this study is to determine wether celecoxib combined with ursodeoxycholic acid is an effective chemoprevention strategy to influence the progression of duodenal adenomas to carcinomas in patients with FAP.
intervention:
Drug: Celecoxib
Drug: Ursodeoxycholic acid
Drug: Placebo
study details
study contacts
expertly curated content related to this topic
-
Adenomatous Polyposis Syndromeshttps://www.youtube.com/watch?v=pFn-A2jZ...
-
Ostomy: Diet and Nutrition GuideThis guide provides some basic informati...
-
Familial Adenomatous Polyposis (FAP): InheritedFAP is an inherited colorectal cancer sy...
-
Familial Adenomatous Polyposis in Pediatrics: Natural History, Emerging Surveillance and Management Protocols, Chemo...Familial adenomatous polyposis (FAP) is ...
-
Chemoprevention of Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) has...
-
Precancerous Colorectal Lesions (Review)Colorectal cancer (CRC) is a common and ...
-
The Ileo Neo Rectal Anastomosis: Long-term Results of Surgical Innovation in Patients After Ulcerative Colitis and F...PURPOSE: Restorative proctocolectomy wi...
English
Portuguese
Spanish